The global rabies vaccine market is witnessing steady growth due to increasing government initiatives for rabies prevention, rising vaccination coverage in both humans and animals, and growing investments in public health infrastructure. Rabies remains a significant public health concern in several developing regions, making vaccination one of the most effective strategies for disease prevention. Continuous advancements in cell culture vaccine technologies, expanding veterinary vaccination programs, and increasing collaboration between public health organizations and vaccine manufacturers are further supporting market development.
